site stats

Pegfilgrastim injection spc

WebApr 4, 2024 · Pegfilgrastim ( Neulasta, Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo) is a man-made version of granulocyte colony-stimulating factor (G-CSF), … WebPegfilgrastim is given as a single injection. Note: If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it might be helpful. How Pegfilgrastim Is Given: This medicine can be given as a shot underneath the skin (subcutaneous [SQ]), in pre-filled syringes.

ANNEX I SUMMARY OF PRODUCT …

WebNYVEPRIA™ (pegfilgrastim-apgf) This product information is intended only for residents of the United States. for Consumers: NYVEPRIATM U.S. Patient Product Information NYVEPRIATM Instructions For Use for Healthcare professionals: NYVEPRIA™ U.S. Physician Prescribing Information WebSep 15, 2024 · Stimufend is a clear, colorless, preservative-free solution available as: Injection: 6 mg/0.6 mL in a single-dose pre-filled syringe for manual use only. 4 CONTRAINDICATIONS Stimufend is contraindicated in patients with a history of serious allergic reactions to pegfilgrastim products or filgrastim products. reflection\u0027s t9 https://hirschfineart.com

Pegfilgrastim (Subcutaneous Route) Proper Use - Mayo Clinic

WebNeupogen Singleject 30 MU/0.5 ml solution for injection in a pre-filled syringe Active Ingredient: filgrastim Company: Amgen Ltd See contact details ATC code: L03AA02 About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) This information is for use by healthcare professionals WebFeb 3, 2024 · How to Give Yourself an Injection of Filgrastim (Neupogen®) or Pegfilgrastim (Neulasta®) Using a Prefilled Syringe. Time to Read: About 7 minutes. This information … WebFeb 1, 2024 · Pegfilgrastim injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a substance that is naturally produced in your body called a colony stimulating factor. Pegfilgrastim helps the bone marrow to make new white blood cells. reflection\u0027s t8

Pegfilgrastim (Subcutaneous Route) Side Effects - Mayo Clinic

Category:G-CSF (Granulocyte-colony stimulating factor)

Tags:Pegfilgrastim injection spc

Pegfilgrastim injection spc

Filgrastim Drugs BNF NICE

WebFeb 10, 2024 · Pegfilgrastim stimulates the production, maturation, and activation of neutrophils and activates neutrophils to increase both their migration and cytotoxicity. … Web1 million units of filgrastim solution for injection contains 10 micrograms filgrastim. Medicinal forms There can be variation in the licensing of different medicines containing the same drug. View medicinal form and pricing information Related treatment summaries Neutropenia Other drugs in class Granulocyte-colony stimulating factors Lenograstim

Pegfilgrastim injection spc

Did you know?

WebFeb 1, 2024 · Descriptions. Pegfilgrastim-bmez injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a substance that is naturally produced in your body called a colony stimulating factor. Pegfilgrastim-bmez helps the bone marrow to make new white blood cells. WebFeb 1, 2024 · Adults—6 milligrams (mg) as a single injection under the skin once every cancer treatment cycle. Children weighing more than 45 kilograms (kg)—Dose is based on body weight and must be determined by your doctor. It is usually 6 milligrams (mg) as a single injection under the skin once every cancer treatment cycle.

WebNeulasta® Safety Data Sheet Revision Number: 7 Date Issued 15-Jan-2024 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERSTANDING 1.1 Product identifier Product Name: Neulasta® Common Name: Pegfilgrastim Chemical Name: PEGylated-recombinant methionyl human granulocyte-colony WebPEGFILGRASTIM (PEG fil gra stim) lowers the risk of infection in people who are receiving chemotherapy. It works by helping your body make more white blood cells, which protects …

WebJun 13, 2005 · Pegfilgrastim is a recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy. Brand Names Fulphila, Fylnetra, Neulasta, Udenyca, Ziextenzo Generic Name Pegfilgrastim DrugBank Accession Number DB00019 Background WebActive ingredients. Filgrastim (as Pegfilgrastim) 10 mg per 1 ml. Size. 1. Unit. pre-filled disposable injection. NHS indicative price. £686.37 (Hospital only) Legal category.

WebThese injections encourage your bone marrow to make stem cells and increase the number of stem cells in the blood. How G-CSF is given You usually have G-CSF as an injection …

WebAmgen reflection\u0027s tfWebSynonyms: Pegfilgrastim Injection; Fulphila; Pegfilgrastim 6 mg/0.6 mL Other means of identification Other Information: No other information Recommended use of the chemical and restrictions on use Recommended Use: Pharmaceutical. Use only as directed. The intent of this safety data sheet (SDS) is to provide safety information for occupational ... reflection\u0027s tgWebFeb 1, 2024 · Adults—6 milligrams (mg) as a single injection under the skin once every cancer treatment cycle. Children weighing more than 45 kilograms (kg)—Dose is based on … reflection\u0027s toWebpegfilgrastim should be discontinued at the discretion of the physician and the appropriate treatment given (see section 4.8). Glomerulonephritis . Glomerulonephritis has been … reflection\u0027s tkWebThe recommended dosage of Neulasta is a single subcutaneous injection of 6 mg administered once per chemotherapy cycle. For dosing in pediatric patients weighing less than 45 kg, refer to Table 1. Do not administer Neulasta between 14 days before and 24 hours after administration of cytotoxic chemotherapy. reflection\u0027s thWebNeulasta® (pegfilgrastim) Onpro® Helping Prevent FN Strong chemotherapy fights cancer. But it can also put you at risk for infection—and that can disrupt your cancer treatment … reflection\u0027s teWebThe granulocyte colony-stimulating factor (G-CSF) receptor through which pegfilgrastim products and filgrastim products act has been found on tumor cell lines. The possibility that pegfilgrastim products act as a growth factor for any tumor type, including myeloid malignancies and myelodysplasia, diseases for reflection\u0027s tj